HOME >> MEDICINE >> NEWS
Panel offers guidelines on skin reactions to new class of cancer drugs

DURHAM, N.C., May 22 -- Skin reactions to a powerful new class of anti-cancer drugs are frequent, but manageable through a simple and rational treatment approach usually without the need to reduce the dose or interrupt treatment with potentially life-prolonging chemotherapy, according to an article in the May issue of "The Oncologist."

The special article presents the first recommendations on skin reactions to the new drugs, called Epidermal Growth Factor Receptor Inhibitors (EGFRIs). The guidelines were developed at an international multidisciplinary meeting, including medical oncologists, dermatologists, nurses, and pharmacists. "One important goal is to ensure that healthcare professionals and patients see EGFRI-associated dermatologic toxicity as manageable, thereby optimizing clinical benefit from continued and uninterrupted use of EGFRIs when possible," according to lead author Dr. Thomas J. Lynch, Jr., of Massachusetts General Hospital, Boston.

Treatment with EGFRIs has been shown to improve survival in patients with several types of cancer, including lung, pancreatic, and colorectal cancers. The drugs including erlotinib (Tarceva), cetuximab (Erbitux), and panitumumab (Vectibix) work by interfering with cell-signaling abnormalities that contribute to cancer development and growth.

Unfortunately, the EGFRIs carry a substantial risk of skin reactions more than half of treated patients have some type of skin toxicity, most commonly an acne-like rash. The reactions most likely occur because the receptor blocked by the drugs also performs key functions in normal skin. There is even evidence that the rash may be a sign that EGFRI anti-cancer treatment is working in some studies, patients with more severe skin reactions had better survival. The skin reactions are rarely so severe that the dosage is reduced or treatment stopped. Until recently, there was no strong scientific data to guide the treatment of skin reactions to EGFRIs
'"/>

Contact: George Kendall
gkendall@alphamedpress.com
919-680-0011
AlphaMed Press, Inc.
23-May-2007


Page: 1 2 3

Related medicine news :

1. Panel offers expert analysis on causes, prevention of stent thrombosis
2. Panel presents Agricultural Biosecurity & Sustainability Strategies at 2007 AAAS Meeting
3. Panel updates guidelines for treatment of adult HIV infection
4. Panel finds insufficient evidence to recommend for or against maternal-request Caesarean delivery
5. Panel calls for a new look at treatments commonly used for chronic insomnia
6. Hormone therapy offers new hope for ovarian cancer patients
7. TB test offers patients quicker and easier diagnosis
8. Supersize me mice research offers grim warning for Americas fast food consumers
9. New treatment offers relief from chronic back pain
10. Commonly used drug offers promise for premature babies
11. Stenting of abdominal arteries offers welcome relief for intestinal angina

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... Tenn. (PRWEB) , ... October 10, 2019 , ... ... of management consulting and information technology (IT) services for the healthcare industry, has ... the Public Hospitals Authority (PHA) of the Commonwealth of The Bahamas towards a ...
(Date:10/8/2019)... ... October 08, 2019 , ... What unique insights can ... state of aging and wellness in the nation? That question will be answered at ... Conference, Leadership Summit and Expo. The event will take place October 10-12, 2019, at ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... for the Department of Veterans Affairs Community Care Referrals and Authorizations program. The ... the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by community ...
(Date:10/8/2019)... ... ... Over the past three decades, Buffalo Wings & Rings has elevated the chicken wing ... higher-quality product and experience than the competition. Now, the club-level sports restaurant brand has ... THE CAUSE" campaign in support of Breast Cancer Awareness Month. , “We are ...
(Date:10/8/2019)... ... October 08, 2019 , ... The University of California San ... Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. ... promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital ...
Breaking Medicine News(10 mins):
(Date:10/22/2019)... , ... October 22, 2019 , ... ... the 2019 Excellency in Advocacy Award for Excellence in a State Issue Campaign ... initiative, SUNucate , and the contributions of ASDSA’s Advocacy team: Kristin Hellquist, ...
(Date:10/19/2019)... ... October 18, 2019 , ... Whealthcare Planning, the industry’s only ... growing momentum for the company and its technology, along and a corresponding capital ... wealthmanagement.com’s Industry Awards Program, Whealthcare Planning was recognized for Technology Thought Leadership for ...
(Date:10/19/2019)... ... ... Hospital M&A activity held steady with 21 transactions in both the second ... recent quarter was down 20% compared with the same period in 2018, when 25 ... nearly $5.0 billion, a 291% increase. Year over year, Q3:19 spending was down 41% ...
Breaking Medicine Technology:
Cached News: